Skip to main content
main-content
Erschienen in: Allergo Journal 7/2020

03.11.2020 | Allergien und Intoleranzreaktionen | Titel Zur Zeit gratis

Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie

Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D

verfasst von: Prof. Dr. med. Ludger Klimek, Prof. Dr. med. Margitta Worm, Dr. med. Lars Lange, Prof. Dr. med. Kirsten Beyer, Priv.-Doz. Dr. med. Ernst Rietschel, Prof. Dr. med. Christian Vogelberg, Sabine Schnadt, Britta Stöcker, Prof. Dr. med. Knut Brockow, Dr. med. Jan Hagemann, Prof. Dr. Dr. med. Thomas Bieber, Prof. Dr. med. Wolfgang Wehrmann, PD Dr. med. Sven Becker, Laura Freudelsperger, Dr. med. Norbert K. Mülleneisen, Katja Nemat, Prof. Dr. med. Wolfgang Czech, Holger Wrede, Prof. Dr. med. Randolf Brehler, Prof. Dr. med. Thomas Fuchs, Stephanie Dramburg, Prof. Dr. med. Paolo Matricardi, Prof. Dr. med. Eckard Hamelmann, Prof. Dr. med. Thomas Werfel, Priv.-Doz. Dr. med. Martin Wagenmann, Prof. Dr. med. Christian Taube, Prof. Dr. med. Torsten Zuberbier, Prof. Dr. med. Dr. phil. Johannes Ring

Erschienen in: Allergo Journal | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Auszug

Eingang
Literatur
1.
Zurück zum Zitat Coronaviridae Study Group of the International Committee on Taxonomy of Viruses: The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses: The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44
2.
Zurück zum Zitat Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine 2020;382:1199-207 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine 2020;382:1199-207
3.
Zurück zum Zitat Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33
4.
Zurück zum Zitat Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39 Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39
5.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506
6.
Zurück zum Zitat Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol 2004;1:119-22 Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol 2004;1:119-22
7.
Zurück zum Zitat Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92:418-23 Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92:418-23
8.
Zurück zum Zitat WHO. Wold Health Organization. 2020. www.who.int. Accessed 14.05.2020 WHO. Wold Health Organization. 2020. www.who.int. Accessed 14.05.2020
9.
Zurück zum Zitat Zhang J-J, Dong X, Cao Y-Y, Yuan Y-D, Yang Y-B, Yan Y-Q et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41 Zhang J-J, Dong X, Cao Y-Y, Yuan Y-D, Yang Y-B, Yan Y-Q et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41
10.
Zurück zum Zitat Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
11.
Zurück zum Zitat Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69:1026-45 Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69:1026-45
12.
Zurück zum Zitat Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J et al. Guideline for acute therapy und management of anaphylaxis. S2 guideline of DGAKI, AeDA, GPA, DAAU, BVKJ, ÖGAI, SGAI, DGAI, DGP, DGPM, AGATE and DAAB. Allergo J Int 2014;23:96-112 Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J et al. Guideline for acute therapy und management of anaphylaxis. S2 guideline of DGAKI, AeDA, GPA, DAAU, BVKJ, ÖGAI, SGAI, DGAI, DGP, DGPM, AGATE and DAAB. Allergo J Int 2014;23:96-112
13.
Zurück zum Zitat Ring J, Beyer K, Biedermann T, Bircher A, Fischer M, Fuchs T, et al. Guidelines (S2) to acute therapy and management of anaphylaxis - update 2020. Allergo J Int 2020; in press Ring J, Beyer K, Biedermann T, Bircher A, Fischer M, Fuchs T, et al. Guidelines (S2) to acute therapy and management of anaphylaxis - update 2020. Allergo J Int 2020; in press
14.
Zurück zum Zitat Wantke F. Anaphylaxie - ein Überblick. Facharzt Dermatologie. 2008;4:6-9 Wantke F. Anaphylaxie - ein Überblick. Facharzt Dermatologie. 2008;4:6-9
15.
Zurück zum Zitat Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy 2010;95:12-21 Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy 2010;95:12-21
16.
Zurück zum Zitat Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy 2012;67:1451-6 Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy 2012;67:1451-6
17.
Zurück zum Zitat Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285-90 Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285-90
18.
Zurück zum Zitat Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. J Allergy Clin Immunol 2016;139:182-8.e2. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. J Allergy Clin Immunol 2016;139:182-8.e2.
19.
Zurück zum Zitat Mullins RJ, Dear KBG, Tang MLK. Time trends in Australian hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol 2015;136:367-75 Mullins RJ, Dear KBG, Tang MLK. Time trends in Australian hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol 2015;136:367-75
20.
Zurück zum Zitat Tejedor-Alonso MA, Moro-Moro M, Mosquera González M, Rodriguez-Alvarez M, Pérez Fernández E, Latasa Zamalloa P et al. Increased incidence of admissions for anaphylaxis in Spain 1998-2011. Allergy 2015;70:880-3 Tejedor-Alonso MA, Moro-Moro M, Mosquera González M, Rodriguez-Alvarez M, Pérez Fernández E, Latasa Zamalloa P et al. Increased incidence of admissions for anaphylaxis in Spain 1998-2011. Allergy 2015;70:880-3
21.
Zurück zum Zitat 21. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015;135:956-63.e1 21. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015;135:956-63.e1
22.
Zurück zum Zitat Armstrong N, Wolff R, van Mastrigt G, Martinez N, Hernandez AV, Misso K et al. A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis. Health Technol Assess 2013;17:1-117,v-vi Armstrong N, Wolff R, van Mastrigt G, Martinez N, Hernandez AV, Misso K et al. A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis. Health Technol Assess 2013;17:1-117,v-vi
23.
Zurück zum Zitat Worm M, Grünhagen J, Dölle S. Nahrungsmittelanaphylaxie. Daten aus dem deutschsprachigen Anaphylaxie-Register 2006 - 2015. Food induced anaphylaxis. Data from the anaphylaxis registry 2006-2015. Allergologie 2016;39:390 Worm M, Grünhagen J, Dölle S. Nahrungsmittelanaphylaxie. Daten aus dem deutschsprachigen Anaphylaxie-Register 2006 - 2015. Food induced anaphylaxis. Data from the anaphylaxis registry 2006-2015. Allergologie 2016;39:390
24.
Zurück zum Zitat Worm M, Eckermann O, Dölle S, Aberer W, Beyer K, Hawranek T et al. Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int 2014;111:367-75 Worm M, Eckermann O, Dölle S, Aberer W, Beyer K, Hawranek T et al. Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int 2014;111:367-75
25.
Zurück zum Zitat Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virolol 2011;1:226-32 Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virolol 2011;1:226-32
26.
Zurück zum Zitat Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe 2016;19:181-93 Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe 2016;19:181-93
27.
Zurück zum Zitat Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 2020;71:778-85 Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 2020;71:778-85
28.
Zurück zum Zitat Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 2020;26:453-5 Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 2020;26:453-5
29.
Zurück zum Zitat To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20:565-74 To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20:565-74
30.
Zurück zum Zitat Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y et al. Risk factors for severity and mortality in adult COVID-19inpatients in Wuhan. J Allergy Clin Immunol 2020;146:110-8 Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y et al. Risk factors for severity and mortality in adult COVID-19inpatients in Wuhan. J Allergy Clin Immunol 2020;146:110-8
31.
Zurück zum Zitat Sabogal Piñeros YS, Bal SM, Dijkhuis A, Majoor CJ, Dierdorp BS, Dekker T et al. Eosinophils capture viruses, a capacity that is defective in asthma. Allergy 2019;74:1898-909 Sabogal Piñeros YS, Bal SM, Dijkhuis A, Majoor CJ, Dierdorp BS, Dekker T et al. Eosinophils capture viruses, a capacity that is defective in asthma. Allergy 2019;74:1898-909
32.
Zurück zum Zitat Jackson DJ, Busse WW, Bacharier LB, Kattan M, O'Connor GT, Wood RA et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol 2020;146:203-6.e3 Jackson DJ, Busse WW, Bacharier LB, Kattan M, O'Connor GT, Wood RA et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol 2020;146:203-6.e3
33.
Zurück zum Zitat Bousquet J, Jutel M, Akdis CA, Klimek L, Pfaar O, Nadeau KC et al. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020). Allergy 2020;. https://​doi.​org/​10.​1111/​all.​14471 Bousquet J, Jutel M, Akdis CA, Klimek L, Pfaar O, Nadeau KC et al. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020). Allergy 2020;. https://​doi.​org/​10.​1111/​all.​14471
34.
Zurück zum Zitat Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med 2020;382:2012-22 Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med 2020;382:2012-22
35.
Zurück zum Zitat Dong X, Cao Y-Y, Lu X-X, Zhang J-J, Du H, Yan Y-Q et al. Eleven faces of coronavirus disease 2019. Allergy 2020;75:1699-709 Dong X, Cao Y-Y, Lu X-X, Zhang J-J, Du H, Yan Y-Q et al. Eleven faces of coronavirus disease 2019. Allergy 2020;75:1699-709
36.
Zurück zum Zitat Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int 2020;117:271-8 Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int 2020;117:271-8
37.
Zurück zum Zitat Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574-81 Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574-81
38.
Zurück zum Zitat Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination. J Allergy Clin Immunol 2020;146:1-7 Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination. J Allergy Clin Immunol 2020;146:1-7
39.
Zurück zum Zitat Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis 2020;71:769-77 Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis 2020;71:769-77
40.
Zurück zum Zitat Klimek L, Jakob T. Die Allergologie stellt sich auf Covid-19 ein. Allergo Journal 2020;29(4):3 Klimek L, Jakob T. Die Allergologie stellt sich auf Covid-19 ein. Allergo Journal 2020;29(4):3
41.
Zurück zum Zitat Pfaar O, Klimek L, Jutel M, Akdis CA, Bousquet J, Breiteneder H et al. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14453 Pfaar O, Klimek L, Jutel M, Akdis CA, Bousquet J, Breiteneder H et al. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14453
42.
Zurück zum Zitat Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M et al. A compendium answering 150 questions on COVID-19and SARS-CoV-2. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14449 Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M et al. A compendium answering 150 questions on COVID-19and SARS-CoV-2. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14449
43.
Zurück zum Zitat Klimek L, Becker S, Buhl R, Chaker AM, Huppertz T, Hoffmann TK et al. Positionspapier: Empfehlungen zur Behandlung der chronischen Rhinosinusitis während der COVID-19-Pandemie im deutschen Gesundheitssystem - Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) - Diese Empfehlungen basieren auf dem EAACI Positionspapier "Treatment of chronic RhinoSinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics - An EAACI Position Paper", Allergy 2020 und wurden auf die Situation im deutschen Gesundheitswesen angepasst. Laryngorhinootologie 2020;99:356-64 Klimek L, Becker S, Buhl R, Chaker AM, Huppertz T, Hoffmann TK et al. Positionspapier: Empfehlungen zur Behandlung der chronischen Rhinosinusitis während der COVID-19-Pandemie im deutschen Gesundheitssystem - Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) - Diese Empfehlungen basieren auf dem EAACI Positionspapier "Treatment of chronic RhinoSinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics - An EAACI Position Paper", Allergy 2020 und wurden auf die Situation im deutschen Gesundheitswesen angepasst. Laryngorhinootologie 2020;99:356-64
44.
Zurück zum Zitat Casale TB, Wang J, Nowak-Wegrzyn A. Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic. J Allergy Clin Immunol Pract 2020;8:1795-7 Casale TB, Wang J, Nowak-Wegrzyn A. Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic. J Allergy Clin Immunol Pract 2020;8:1795-7
45.
Zurück zum Zitat Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy 2015;70:227-35 Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy 2015;70:227-35
46.
Zurück zum Zitat Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Claßen M et al. Guidelines on the management of IgE-mediated food allergies. S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int 2015;24:256-93 Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Claßen M et al. Guidelines on the management of IgE-mediated food allergies. S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int 2015;24:256-93
47.
Zurück zum Zitat Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy 2017;73:744-64 Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy 2017;73:744-64
48.
Zurück zum Zitat Klimek L, Jutel M, Akdis C, Bousquet J, Akdis M, Bachert C et al. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy 2020;75:1546-54 Klimek L, Jutel M, Akdis C, Bousquet J, Akdis M, Bachert C et al. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy 2020;75:1546-54
49.
Zurück zum Zitat Klimek L, Pfaar O, Worm M, Bergmann K-C, Bieber T, Buhl R et al. Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie. Allergo J 2020;29(3):17-25 Klimek L, Pfaar O, Worm M, Bergmann K-C, Bieber T, Buhl R et al. Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie. Allergo J 2020;29(3):17-25
50.
Zurück zum Zitat Przybilla B, Rueff F, Walker A, Räwer HC, Aberer W, Bauer CP et al. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo J 2011;20(6):318 Przybilla B, Rueff F, Walker A, Räwer HC, Aberer W, Bauer CP et al. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo J 2011;20(6):318
51.
Zurück zum Zitat Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, et al. Status of healthcare provision to insect venom allergy sufferers during the Covid-19 pandemic. Position paper of the German Society for Allergology and Clinical Immunology (DGAKI). Allergo J Int 2020; (in press) Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, et al. Status of healthcare provision to insect venom allergy sufferers during the Covid-19 pandemic. Position paper of the German Society for Allergology and Clinical Immunology (DGAKI). Allergo J Int 2020; (in press)
52.
Zurück zum Zitat Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Ureña-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P et al. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. Allergy 2015;70:784-94 Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Ureña-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P et al. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. Allergy 2015;70:784-94
53.
Zurück zum Zitat Mack DP, Chan ES, Shaker M, Abrams EM, Wang J, Fleischer DM et al. Novel Approaches to Food Allergy Management During COVID-19Inspire Long-Term Change. J Allergy Clin Immunol Pract 2020;S2213-2198(20)30728-5 Mack DP, Chan ES, Shaker M, Abrams EM, Wang J, Fleischer DM et al. Novel Approaches to Food Allergy Management During COVID-19Inspire Long-Term Change. J Allergy Clin Immunol Pract 2020;S2213-2198(20)30728-5
54.
Zurück zum Zitat Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010;65:1357-66 Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010;65:1357-66
55.
Zurück zum Zitat Gelincik A, Brockow K, Çelik GE, Doña I, Mayorga C, Romano A et al. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14439 Gelincik A, Brockow K, Çelik GE, Doña I, Mayorga C, Romano A et al. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19. Allergy 2020; https://​doi.​org/​10.​1111/​all.​14439
56.
Zurück zum Zitat Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet J-C et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy 2018;74:14-27 Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet J-C et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy 2018;74:14-27
57.
Zurück zum Zitat Absmaier M, Biedermann T, Brockow K. Auslöser von Arzneiexanthemen: Absetzen, durchbehandeln oder desensibilisieren? Der Hautarzt 2017;68(1):29-35 Absmaier M, Biedermann T, Brockow K. Auslöser von Arzneiexanthemen: Absetzen, durchbehandeln oder desensibilisieren? Der Hautarzt 2017;68(1):29-35
58.
Zurück zum Zitat Scherer K, Brockow K, Aberer W, Gooi JH, Demoly P, Romano A et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy 2013;68:844-52 Scherer K, Brockow K, Aberer W, Gooi JH, Demoly P, Romano A et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy 2013;68:844-52
59.
Zurück zum Zitat Westfall TC. Adrenergic agonists and antagonists. In: Chabner BA BL, Knollmann BC, editors. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: Mc Graw-Hill, 2006: p. 215-268 Westfall TC. Adrenergic agonists and antagonists. In: Chabner BA BL, Knollmann BC, editors. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: Mc Graw-Hill, 2006: p. 215-268
60.
Zurück zum Zitat Fromer L. Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector. Am J Med 2016;129:1244-50 Fromer L. Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector. Am J Med 2016;129:1244-50
61.
Zurück zum Zitat Kemp SF, Lockey RF, Simons FER. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63:1061-70 Kemp SF, Lockey RF, Simons FER. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63:1061-70
62.
Zurück zum Zitat Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence Base. Int Arch Allergy Immunol 2013;162:193-204 Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence Base. Int Arch Allergy Immunol 2013;162:193-204
63.
Zurück zum Zitat Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol 2016;137:1128-37.e1 Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol 2016;137:1128-37.e1
64.
Zurück zum Zitat Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-4 Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-4
65.
Zurück zum Zitat Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy 2016;9:93-100 Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy 2016;9:93-100
66.
Zurück zum Zitat Caffarelli C, Garrubba M, Greco C, Mastrorilli C, Povesi Dascola C. Asthma and Food Allergy in Children: Is There a Connection or Interaction? Front Pediatr 2016;4:34 Caffarelli C, Garrubba M, Greco C, Mastrorilli C, Povesi Dascola C. Asthma and Food Allergy in Children: Is There a Connection or Interaction? Front Pediatr 2016;4:34
67.
Zurück zum Zitat González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010;125:1098-104.e1 González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010;125:1098-104.e1
68.
Zurück zum Zitat O'Keefe A, Clarke A, St Pierre Y, Mill J, Asai Y, Eisman H et al. The Risk of Recurrent Anaphylaxis. J Pediatr 2016;180:217-21 O'Keefe A, Clarke A, St Pierre Y, Mill J, Asai Y, Eisman H et al. The Risk of Recurrent Anaphylaxis. J Pediatr 2016;180:217-21
69.
Zurück zum Zitat Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol 2010;104:172-7 Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol 2010;104:172-7
70.
Zurück zum Zitat Klimek L, Jakob T. Editorial. Anaphylaxiepatienten als Aut-idem-Opfer. Allergo Journal 2019;28(6):3 Klimek L, Jakob T. Editorial. Anaphylaxiepatienten als Aut-idem-Opfer. Allergo Journal 2019;28(6):3
71.
Zurück zum Zitat Klimek L, Dramburg S. Jetzt teilnehmen. Allergo Journal 2020;29(5):66 Klimek L, Dramburg S. Jetzt teilnehmen. Allergo Journal 2020;29(5):66
72.
Zurück zum Zitat Klimek L, Hagemann J, Alali A, Spielhaupter M, Huppertz T, Hörmann K et al. Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19. Allergy 2020. https://​doi.​org/​10.​1111/​all.​14467 Klimek L, Hagemann J, Alali A, Spielhaupter M, Huppertz T, Hörmann K et al. Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19. Allergy 2020. https://​doi.​org/​10.​1111/​all.​14467
73.
Zurück zum Zitat Matricardi PM, Dramburg S, Alvarez-Perea A, Antolín-Amérigo D, Apfelbacher C, Atanaskovic-Markovic M et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy 2019;75:259-72 Matricardi PM, Dramburg S, Alvarez-Perea A, Antolín-Amérigo D, Apfelbacher C, Atanaskovic-Markovic M et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy 2019;75:259-72
Metadaten
Titel
Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie
Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D
verfasst von
Prof. Dr. med. Ludger Klimek
Prof. Dr. med. Margitta Worm
Dr. med. Lars Lange
Prof. Dr. med. Kirsten Beyer
Priv.-Doz. Dr. med. Ernst Rietschel
Prof. Dr. med. Christian Vogelberg
Sabine Schnadt
Britta Stöcker
Prof. Dr. med. Knut Brockow
Dr. med. Jan Hagemann
Prof. Dr. Dr. med. Thomas Bieber
Prof. Dr. med. Wolfgang Wehrmann
PD Dr. med. Sven Becker
Laura Freudelsperger
Dr. med. Norbert K. Mülleneisen
Katja Nemat
Prof. Dr. med. Wolfgang Czech
Holger Wrede
Prof. Dr. med. Randolf Brehler
Prof. Dr. med. Thomas Fuchs
Stephanie Dramburg
Prof. Dr. med. Paolo Matricardi
Prof. Dr. med. Eckard Hamelmann
Prof. Dr. med. Thomas Werfel
Priv.-Doz. Dr. med. Martin Wagenmann
Prof. Dr. med. Christian Taube
Prof. Dr. med. Torsten Zuberbier
Prof. Dr. med. Dr. phil. Johannes Ring
Publikationsdatum
03.11.2020

Weitere Artikel der Ausgabe 7/2020

Allergo Journal 7/2020 Zur Ausgabe

Kongressabstracts

Herzlich Willkommen!

AeDA/DGAKI informieren

Ein Rückblick in Bildern

Corona-Update

Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.